Ronald M Kurtz MD insider trades
Open-market stock purchases and sales by Ronald M Kurtz MD, Chief Medical Officer at RxSight, Inc, from SEC Form 4 filings since Jul 31, 2021.
Track record: 0% of 2 scored buys are up 5% or more since purchase, averaging -66%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Sep 5, 2026 | RXST RxSight, Inc | Bought (not open market) | $1.6M |
| Sep 5, 2026 | RXST RxSight, Inc | Sold (not open market) | $5.4M |
| Sep 5, 2026 | RXST RxSight, Inc | Sold (not open market) | $3M |
| Sep 5, 2026 | RXST RxSight, Inc | Sold (not open market) | $8.4M |
| Sep 5, 2026 | RXST RxSight, Inc | Sold (not open market) | $6.1M |
| Sep 5, 2026 | RXST RxSight, Inc | Bought (not open market) | $1.1M |
| Sep 5, 2026 | RXST RxSight, Inc | Bought (not open market) | $613K |
| Sep 5, 2026 | RXST RxSight, Inc | Bought (not open market) | $1M |
| Sep 2, 2026 | RXST RxSight, Inc | Sold | $35.5K |
| Aug 31, 2026 | RXST RxSight, Inc | Bought (not open market) | — |
| Aug 31, 2026 | RXST RxSight, Inc | Bought (not open market) | — |
| Feb 27, 2026 | RXST RxSight, Inc | Bought (not open market) | — |
Companies traded
- RXST RxSight, Inc: 2 buys, 5 sales, last Sep 5, 2026